Characterizing hepatitis B virus infection in children in the Democratic Republic of Congo to inform elimination efforts
Camille E Morgan,Kimberly A Powers,Jessie K Edwards,Marcel Yotebieng,Michael Emch,Stane Biju,Upasana Devkota,Gavin Cloherty,Feng-Chang Lin,Jeremie Muwonga,John Schmitz,Melchior Mwandagalirwa Kashamuka,Pascal Tshiamala,Aimee Mboyo,Antoinette Tshefu,Sylvia Becker-Dreps,Jonathan B Parr,Peyton Thompson
DOI: https://doi.org/10.1101/2024.06.12.24308840
2024-06-13
Abstract:Objective:
Despite global reductions in hepatitis B virus (HBV) prevalence, an estimated 6.2 million children are infected, two-thirds of whom live in the WHO Africa region. We sought to characterize childhood HBV to inform elimination efforts in the Democratic Republic of Congo (DRC), one of the largest and most populous African countries.
Methods:
Using the most recent (2013-14) nationally representative Demographic and Health Survey in the DRC, we analyzed HBV surface antigen (HBsAg) on dried blood spots and associated survey data from children aged 6-59 months. We estimated HBsAg-positivity prevalence nationally, regionally, and by potential correlates of infection. We evaluated spatial variation in HBsAg-positivity prevalence, overall and by age, sex, and vaccination status.
Findings:
Using data from 5,679 children, we found national HBsAg-positivity prevalence was 1.3% (95% CI: 0.9%-1.7%), but ranged from 0.0% in DRC's capital city province, Kinshasa, to 5.6% in northwestern Sud-Ubangi Province. Prevalence among boys (1.8%, 95% CI: 1.2%-2.7%) was double that among girls (0.7%, 95%CI: 0.4%-1.3%). Tetanus antibody-negativity, rurality, and lower household wealth were also significantly associated with higher HBsAg-positivity prevalence. We observed no difference in prevalence by age. Children had higher HBsAg-positivity odds if living with ≥1 HBsAg-positive adult household member (OR: 2.3, 95%CI: 0.7-7.8), particularly an HBsAg-positive mother (OR: 7.2, 95%CI:1.6-32.2).
Conclusion:
In the largest national survey of HBV among children and household contacts in the DRC, we found that childhood HBV prevalence was 10-60 times the global target of 0.1%. We highlight specific regions and populations for further investigation and focused prevention efforts.
Infectious Diseases (except HIV/AIDS)